Mesenchymal stem cells in a transgenic mouse model of multiple system atrophy: immunomodulation and neuroprotection.
<h4>Background</h4>Mesenchymal stem cells (MSC) are currently strong candidates for cell-based therapies. They are well known for their differentiation potential and immunoregulatory properties and have been proven to be potentially effective in the treatment of a large variety of diseas...
Saved in:
| Main Authors: | Sylvia Stemberger, Angelika Jamnig, Nadia Stefanova, Günter Lepperdinger, Markus Reindl, Gregor K Wenning |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2011-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0019808&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Involvement of Peripheral Nerves in the Transgenic PLP-α-Syn Model of Multiple System Atrophy: Extending the Phenotype.
by: Daniela Kuzdas-Wood, et al.
Published: (2015-01-01) -
Differences of Clonogenic Mesenchymal Stem Cells on Immunomodulation of Lymphocyte Subsets
by: Pascual Martínez-Peinado, et al.
Published: (2018-01-01) -
Changes in the miRNA-mRNA Regulatory Network Precede Motor Symptoms in a Mouse Model of Multiple System Atrophy: Clinical Implications.
by: Simon Schafferer, et al.
Published: (2016-01-01) -
Matrix stiffness and viscoelasticity influence human mesenchymal stem cell immunomodulation
by: Sara J. Olsen, et al.
Published: (2025-03-01) -
Neural stem cell-derived extracellular vesicles: mini players with key roles in neurogenesis, immunomodulation, neuroprotection and aging
by: Valentina Bonetto, et al.
Published: (2023-05-01)